Kenvue narrowly missed Wall Street estimates for second-quarter results as inflation, tariffs, and currency-related costs squeezed margins. Adjusted gross margin fell to 60.2% from 60.9% a year earlier, while adjusted profit came in at 31 cents per share, just below the 32-cent analyst estimate. Quarterly sales rose 3% to $3.96 billion, slightly missing the $3.97 billion consensus. The consumer-health company, currently in the midst of a $40 billion buyout by Kimberly-Clark, expects the deal to close in the fourth quarter of 2026.
Kenvue Inc.Kenvue missed Q2 estimates on margins and profit due to inflation, tariffs, and currency costs.
Kimberly-Clark CorporationKenvue's acquisition by Kimberly-Clark is progressing, with deal expected to close in Q4 2026.
